Spots Global Cancer Trial Database for l3 childhood acute lymphoblastic leukemia

Every month we try and update this database with for l3 childhood acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma	NCT00002757	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisolone prednisone therapeutic hyd... vincristine sul...	- 20 Years	Children's Oncology Group
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma	NCT00002471	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... methotrexate methylprednisol... therapeutic hyd... thiotepa vincristine sul...	-	Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia	NCT00005977	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul...	- 22 Years	Children's Oncology Group
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia	NCT00058461	B-cell Childhoo... Childhood Burki... Childhood Diffu... Childhood Immun... L3 Childhood Ac... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child...	ifosfamide etoposide rituximab carboplatin filgrastim methotrexate cytarabine laboratory biom...	- 21 Years	National Cancer Institute (NCI)
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma	NCT00002757	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisolone prednisone therapeutic hyd... vincristine sul...	- 20 Years	Children's Oncology Group
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia	NCT00058461	B-cell Childhoo... Childhood Burki... Childhood Diffu... Childhood Immun... L3 Childhood Ac... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child...	ifosfamide etoposide rituximab carboplatin filgrastim methotrexate cytarabine laboratory biom...	- 21 Years	National Cancer Institute (NCI)
Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia	NCT00005945	Leukemia	cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate pegaspargase thioguanine vincristine sul... radiation thera...	1 Year - 9 Years	Children's Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: